Social Welfare Corporation Uji Hospital, Kyoto, Japan Introduction: Maladaptive hypertrophy is being recognized as a critical event during the development of heart failure. We found that nobiletin, a poly-methoxy flavonoids derived from Citrus unshu, repressed hypertrophic responses in cardiomyocytes and prevented the development of heart failure after myocardial infarction in rats. Thus, nobiletin is expected as a useful agent for heart failure. However, the target molecule of nobiletin in cardiomyocytes is still unclear. Methods and Results: First, we investigated the localization of nobiletin within cardiomyocytes by generating nobiletin conjugated with Tokyo-green, a fluorescein analogue (TG-nobiletin). We confirmed that TG-nobiletin retains its ability to inhibit cardiomyocyte hypertrophy in a manner similar with natural nobiletin, and found TG-nobiletin was distributed in a cytoplasm of cardiomyocytes. Next, to identify nobiletin-binding proteins (NBPs), we synthesized biotin-conjugated nobiletin (Bio-nobiletin). Protein extracts form rat hearts were incubated with Bio-nobiletin or Biotin alone and binding proteins were precipitated with streptavidin beads. By mass-spectrometric analysis, we identified 162 novel NBPs in the heart. In addition, Bionobiletin pull-down assay showed that Bio-nobiletin could interact with recombinant NBP1, which related to metabolic processes. In cultured cardiomyocytes, knockdown of NBP1 lost the inhibitory effects of nobiletin against phenylephrine-induced cardiomyocyte hypertrophy. Conversely, overexpression of NBP1 inhibited phenylephrine-induced hypertrophy. Conclusions: These results suggest that NBP1 may be a novel molecular target of nolitetin, a potent therapeutic agent for cardiac hypertrophy.
O-007
Mitochondrial Purpose: We previously reported that glucose uptake increased markedly and fatty acid uptake decreased at the congestive heart failure (CHF) stage, associated with decreased gene expression related to mitochondrial function in a rat model of heart failure. The purpose of the study was to clarify the link between the changes of substrate utilization and mitochondrial function. Methods and Results: Carbonyl cyanide m-chlorophenylhydrazone (CCCP), a compound known to reduce the mitochondrial membrane potential, was injected intraperitoneally into SpragueDawley rats. The rats administered CCCP showed a transiently decreased systolic function on echocardiography and a decrease in cardiac phosphocreatine and ATP compared to the vehicle group on in vivo 31 P magnetic resonance spectroscopy. Since ATP was mainly produced by mitochondrial membrane potentials, decreased ATP caused by CCCP injection means dispersion of the mitochondrial function. In ex vivo perfused hearts, CCCP also decreased the mitochondrial membrane potential assessed by two-photon laser microscopy. The glucose uptake increased 1.96 fold compared to the vehicle group and the fatty acid uptake decreased 0.48 fold 90 minutes after CCCP administration, indicating that mitochondrial dysfunction caused the changes in substrate uptake. Conclusions: This rat model using CCCP could be used as a model of mitochondrial dysfunction. Mitochondrial dysfunction may be closely associated with metabolic substrat switching in the heart, especially in the failing heart. Mitochondria play a crucial role in the development of various cardiovascular diseases. The aim of the study was to elucidate the role of mitochondrial dysfunction and oxidative stress in hypertrophic cardiomyopathy (HCM).
O-008
The cardiac and skeletal muscle were obtained from 9 spontaneously-occurring domestic HCM cats with preserved systolic function and 13 age-matched control cats. The capacities of mitochondrial oxidative phosphorylation (OXPHOS) and fatty acid oxidation were assessed with permeabilized muscle fibers and isolated mitochondria by using high-resolution respirometry. Reactive oxygen species (ROS) generation originated from isolated mitochondria was assessed by using spectrofluorometer. Thiobarbituric reactive substances (TBARS), lipid peroxides, were also measured as an oxidative stress marker. Mitochondrial state 3 respiration with complex I-linked substrates and fatty acid oxidation in the heart were significantly depressed in HCM cats. Furthermore, mitochondrial ROS generation during state 3 with complex I-linked substrates and TBARS in the heart were significantly greater in HCM cats. In contrast, there were no significant differences in mitochondrial function and oxidative stress in the skeletal muscle. Mitochondrial OXPHOS capacity with complex I-linked substrates and fatty acid oxidation were impaired with enhanced mitochondrial oxidative stress in feline HCM heart. These findings provide new insight into pathophysiology of HCM and support the hypothesis that to restore normal redox-state is beneficial in the treatment of HCM.
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Mst1 Plays a Cell-protective Role in the Heart Through FoxO1 and C/EBP-b Phosphorylation YASUHIRO MAEJIMA Mst1 kinase promotes apoptosis, thereby playing a crucial role in mediating cardiac dysfunction in response to stress. Mst1 also stimulates a cell-protective mechanism through FoxO1 as negative feedback to counteract its strong pro-apoptotic actions. In order to clarify how Mst1 mediates this cell-protective mechanism in the heart, Tg-DN-Mst1 were subjected to 2-h of prolonged ischemia. Tg-DN-Mst1 hearts exhibited a significantly greater infarcted area than wild-type hearts, suggesting that the cardioprotective effect of Mst1 dominates the pro-apoptotic effect. FoxO1 upregulated antioxidant genes, including catalase, and inhibited pro-apoptotic genes, including FasL, in cardiomyocytes, and these effects upon gene expression were attenuated when endogenous Mst1 was inhibited. Chromatin immunoprecipitation assays revealed that 
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Wnt/b-catenin Signaling Promotes Heart Failure-Induced Skeletal Myopathy through Direct Interaction with FoxO KATSUKI OKADA 1 , ATSUHIKO NAITO
